Medikit Co.,Ltd. (TYO:7749)
Japan · Delayed Price · Currency is JPY 2,806.00
-44.00 (-1.54%)
Jun 2, 2026, 2:47 PM JST
Medikit Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 23,781 | 22,553 | 21,850 | 21,607 | 20,130 | |
Revenue Growth (YoY) | 5.45% | 3.22% | 1.13% | 7.34% | 4.24% |
Cost of Revenue | 14,774 | 13,885 | 13,098 | 13,289 | 11,949 |
Gross Profit | 9,007 | 8,668 | 8,752 | 8,318 | 8,181 |
Selling, General & Admin | 4,735 | 3,846 | 3,747 | 3,932 | 3,527 |
Amortization of Goodwill & Intangibles | - | 217 | 230 | 41 | - |
Operating Expenses | 4,736 | 4,182 | 4,077 | 4,204 | 3,762 |
Operating Income | 4,271 | 4,486 | 4,675 | 4,114 | 4,419 |
Interest Expense | -7 | -7 | -7 | -7 | -7 |
Interest & Investment Income | 66 | 32 | 19 | 18 | 40 |
Currency Exchange Gain (Loss) | 44 | 23 | -10 | -28 | -3 |
Other Non Operating Income (Expenses) | 85 | 99 | 84 | 63 | 84 |
EBT Excluding Unusual Items | 4,459 | 4,633 | 4,761 | 4,160 | 4,533 |
Gain (Loss) on Sale of Investments | - | - | -4 | 124 | -50 |
Gain (Loss) on Sale of Assets | 54 | 26 | 19 | 21 | -5 |
Asset Writedown | -1 | - | -1 | -15 | -5 |
Other Unusual Items | - | - | -1 | - | -1 |
Pretax Income | 4,512 | 4,659 | 4,774 | 4,290 | 4,472 |
Income Tax Expense | 1,506 | 1,646 | 1,705 | 1,426 | 1,479 |
Net Income | 3,006 | 3,013 | 3,069 | 2,864 | 2,993 |
Net Income to Common | 3,006 | 3,013 | 3,069 | 2,864 | 2,993 |
Net Income Growth | -0.23% | -1.82% | 7.16% | -4.31% | 12.56% |
Shares Outstanding (Basic) | 15 | 15 | 16 | 17 | 17 |
Shares Outstanding (Diluted) | 15 | 15 | 16 | 17 | 17 |
Shares Change (YoY) | -1.12% | -9.79% | -2.70% | -0.10% | -0.57% |
EPS (Basic) | 206.36 | 204.52 | 187.92 | 170.64 | 178.14 |
EPS (Diluted) | 206.36 | 204.52 | 187.92 | 170.64 | 178.14 |
EPS Growth | 0.90% | 8.83% | 10.13% | -4.21% | 13.20% |
Free Cash Flow | 1,293 | -256 | 3,146 | 3,497 | 1,374 |
Free Cash Flow Per Share | 88.77 | -17.38 | 192.64 | 208.35 | 81.78 |
Dividend Per Share | - | 90.000 | 80.000 | 70.000 | 60.000 |
Dividend Growth | - | 12.50% | 14.29% | 16.67% | 20.00% |
Gross Margin | 37.88% | 38.43% | 40.05% | 38.50% | 40.64% |
Operating Margin | 17.96% | 19.89% | 21.40% | 19.04% | 21.95% |
Profit Margin | 12.64% | 13.36% | 14.05% | 13.26% | 14.87% |
Free Cash Flow Margin | 5.44% | -1.14% | 14.40% | 16.18% | 6.83% |
EBITDA | 6,309 | 6,175 | 6,219 | 5,437 | 5,688 |
EBITDA Margin | 26.53% | 27.38% | 28.46% | 25.16% | 28.26% |
D&A For EBITDA | 2,038 | 1,689 | 1,544 | 1,323 | 1,269 |
EBIT | 4,271 | 4,486 | 4,675 | 4,114 | 4,419 |
EBIT Margin | 17.96% | 19.89% | 21.40% | 19.04% | 21.95% |
Effective Tax Rate | 33.38% | 35.33% | 35.71% | 33.24% | 33.07% |